The Effects of Acute vs. Chronic of Screen Illumination on: Sleep Efficacy and Architecture, Physiology, Emotion and Behavior: Possible Effect on Human Health

NCT ID: NCT02839395

Last Updated: 2018-01-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

19 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-08-31

Study Completion Date

2016-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The human eye has a dual role, which is reflected by the various photo-receptors used for vision of images and colors ,Image forming photoreceptors (IFP) and for entrainment of our "Biological clock" located in the hypothalamus through the retinal ganglions known as non-image forming photoreceptors (NIFP). The recently discovered new photo-pigment melanopsin which is sensitive to short wavelength (SWL) illumination exists in the-NIFP. The axons of the NIFP form a special nerve known as the Retino-hypothalamic-tract (RHT) that transfers the SWL signal to the biological clock resulting in suppression of pineal melatonin (MLT) production. This is the basic mechanism by which environmental light/dark cycles entrain the biological clock and transfer the message to organs, tissues and cell.

The American Medical Association (AMA) issued a resolution in 2012 stating that light at night constitutes environmental pollution because it violates the daily cycles, including the waking and sleeping cycles, and suppresses the secretion of melatonin from the pineal gland at night. Results of other studies have shown that exposure to artificial light at night (ALAN) and mainly those emerging from SWL sources suppresses MLT-produced in the pineal gland. Computers, tablets, TVs, and smart-phones screens emit SWL illumination, during the day and night hours, whether as active or passive users. The results of previous studies show that, exposure to SWL-ALAN illumination suppresses MLT-secretion and disrupts sleep patterns. In order to understand better the effect of SWL-exposure emerging from screens on human behavior and health, the investigators will study the effects of SWL-exposure on the structure and quality of sleep, cognitive functioning in Continous Performance Test (CPT III), emotional state, and physiological, variables (melatonin secretion levels and body temperature) that were not tested in previous studies.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators will examine whether there is a difference between one-time and multiple exposures to computer screen lighting (350 lux). The investigators hypothesize that multiple and continuous exposure will have a more significant detrimental effect on the quality of sleep and consequently on performance, emotional, and physiological indicators, than one-time exposure to screen light.

Procedure:

On the base-line, first and fifth night of the study, at the end of two hours of exposure to screen light, the subject will be connected to the sleep test system by a skilled technician. On all other nights (nights 2-4), exposure to computer light only, will be conducted and at the end of the exposure the subject will be asked to go to sleep. During the entire experimental period the subject will wear an Actigraph watch to ensure regular sleeping hours. In addition, subjects will be asked not to expose themselves to a computer/tablet/smartphone screen from 20:00 h to wake up.

An Actigraph will monitor their sleep during the week of the experiment. The subject will be invited to attend the Sleep Institute at 21:00 h. The subject will be asked to enter the test room, which will be dark, and sit in front of a computer screen for two hours at a distance of about 60 cm from the screen and perform the on-screen tasks between the hours of 21:00 and 23:00 h. The tasks will include: reading and writing Microsoft Word documents, , and answering questions dealing with a document read and, solving verbal and arithmetic problems, while attempting to accomplish the task correctly and in the quickest time possible. The subject will be told that the purpose of the study is to examine the effect of the content of the tasks on the quality of sleep. During exposure, the subject will be allowed to eat and drink, but do not go to the bathroom. At the end of two hours of exposure to screen light, the subject will be connected to the sleep test system by a skilled technician. Body temperature and 6-hydroxymelatonin sulfate(6-SMT) in the urine will be measured using the on-set and off-set methods three times, at 21:00, 23:00 h, and close to the falling asleep time. Three measurements will be taken after awakening. After the sleep test system is installed, the subject will be asked to go to sleep and in the morning will be woken at his/her average waking time. After the examinee has been woken and has provided a urine sample and body temperature measurement, the sleep test system will be removed and the examinees will be given 30 minutes to organize him/herself, before performing the following tasks to assess his/her degree of fatigue and sleepiness: Continous Performance Test (CPT-III), the Brief Symptoms Inevntory (BSI) emotional questionnaire, and the Epworth Sleepiness Scale (ESS) and Karolinska Sleepiness Scale (KSS) questionnaire.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sleep Emotion

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

base line

First night is the base line- no exposure to computer screen illumination.

Group Type ACTIVE_COMPARATOR

No intervention- base line

Intervention Type OTHER

the subject will sited in a dim light room. No screen light illumination.

Acute

Second night is the acute exposure to computer screen illumination.

Group Type EXPERIMENTAL

Acute

Intervention Type OTHER

The subject will be sited in front of computer screen light illumination for 2 hours.

Chronic

Chronic is the effect after five nights of exposure to computer screen light illumination.

Group Type EXPERIMENTAL

Chronic

Intervention Type OTHER

The subject will be sited in front of computer screen light illumination for 2 hours for 5 consecutive days.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention- base line

the subject will sited in a dim light room. No screen light illumination.

Intervention Type OTHER

Acute

The subject will be sited in front of computer screen light illumination for 2 hours.

Intervention Type OTHER

Chronic

The subject will be sited in front of computer screen light illumination for 2 hours for 5 consecutive days.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age 20-45,
* healthy
* No history of visual disturbances
* No history of sleep disorders

Exclusion Criteria

* score more then 5 in the Pittsburgh Questionnaire (PSQI).
* Subjects with a-typicality deviation in the HORNE - OSTBERG sleep-wakefulness cycle questionnaire.
* One of the Eye problems: field of vision, color blindness, or impaired functioning of the pupil in reaction to light.
* Subjects who did shiftwork three months before the experiment
* Subjects that taking sleeping medications in general and melatonin in particular
Minimum Eligible Age

20 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assuta Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lilach Kemer

Dr.

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0005-16-ASMC

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Color and Pupil Function
NCT02636140 COMPLETED NA
Visual Attention and Eye Movements
NCT03298737 ENROLLING_BY_INVITATION